19 C
Jalandhar
Saturday, April 4, 2026
Home Blog Page 609

Mbappe signs a three-year bargain at PSG in the wake of dismissing Real Madrid.

The Kylian Mbappe move adventure reached a resolution on Saturday in the midst of affirmation the Paris Saint-Germain forward had scorned a transition to Real Madrid for marking a three-year contract expansion at the Ligue 1 club.
Last year, PSG dismissed a progression of offers from Madrid for Mbappe.
The remainder of which really depended on €200 million, and the Spanish monsters had been certain that they would at long last land their long-wanted focus on a free exchange this late spring, His arrangement was due to terminate on June 30.
Be that as it may, a final desperate attempt from PSG to convince Mbappe to remain demonstrated fruitful on Saturday, with the forward swearing his future to the Ligue 1 club until 2025.

“I would like to announce that I have chosen to extend my contract at Paris Saint-Germain, and of course I am delighted,” Mbappe said in a proclamation.

Madrid figured out how to beat PSG in the Champions League this season yet not in the exchange market.
The Spanish monster’s inability to sign Mbappé was a huge blow for its leader, Florentino Pérez, who has been attempting to get the exchange over the line for a year.
Mbappe joined PSG from AS Monaco in 2017, with the club ultimately paying a world-record expense for a youngster of €180m.
He has proceeded to score an aggregate of 168 objectives in five years at the club, making him their second-most noteworthy vocation scorer behind Edinson Cavani.

Jif peanut butter is being reviewed for potential salmonella pollution.

Numerous Jif peanut butter items are being reviewed because of an episode of salmonella connected to a Lexington, Ky., fabricating office.

J.M. Smucker Co., the parent organization for the well*known peanut butter brand, gave an intentional review on Friday. The Food and Drug Administration alongside the Centers for Disease Control and Prevention and local partners and accomplices are researching the episode that up until this point traverses 12 states.

As of now, 14 individuals have revealed diseases and two of those cases have brought about hospitalizations, as per the information given by the CDC.

“Five out of five people reported consuming peanut butter and four of the five people specifically reported consuming different varieties of Jif brand peanut butter prior to becoming ill,” the FDA said.

गहरे बोरवेल में गिरा 6 साल का बच्चा |

गढ़दीवाला (होशियारपुर): गांव खियाला में एक 6 वर्षीय बालक गहरे बोरवेल में गिर गया. मिली जानकारी के अनुसार एक प्रवासी मजदूर का बेटा जो थोड़ा मानसिक विक्षिप्त था. और उसके पीछे कुत्ते थे। कुत्ते के डर से वह बोर पर चढ़ गया और अचानक बोरवेल में गिर गया। मौके पर पहुंचे बाबा मोके विधानसभा क्षेत्र के विधायक जसवीर सिंह राजा और पुलिस प्रशासन ने बच्चे को बोरवेल से बाहर निकालने का प्रयास किया |

Ministry of Culture to commemorate the 250th Birth Anniversary of Raja Ram Mohan Roy from 22nd May 2022 to 22nd May 2023.

Shri G. Kishan Reddy to unveil an iconic statue of Raja Ram Mohan Roy at the inaugural ceremony in Kolkata tomorrow

Under the aegis of Azadi Ka Amrit Mahotsav (AKAM), the Ministry of Culture is commemorating the 250th Birth Anniversary of Shri Raja Ram Mohan Roy from 22nd May 2022 to 22nd May 2023. The inaugural ceremony will take place at Mohan Roy Library Foundation, Salt Lake, Kolkata, and at Science City Auditorium, Kolkata. Union Minister of Culture, Tourism, and Development of North Eastern Region (DoNER) Shri G. Kishan Reddy, and Governor of West Bengal, Shri Jagdeep Dhankhar will be gracing the ceremony on 22nd May 2022.

An iconic statue of Raja Ram Mohan Roy will be unveiled by the Minister of Culture, Shri G. Kishan Reddy in a virtual mode at Mohan Roy Library Foundation, Kolkata at 11:00 AM.

Several other events will also be held at Salt Lake, Science City Auditorium, Kolkata. A seminar and quiz program for children will also be organized. A multimedia presentation on various facts of the life of Shri Raja Ram Mohan Roy will also be presented.

Union Minister Dr Jitendra Singh launches Single National Portal for Biotech researchers and Start-Ups

The Portal BioRRAP will cater to all those seeking regulatory approval required for biological research and development activity in the country
In keeping with the spirit of “One Nation, One Portal”, Union Minister of State (IC) Ministry of Science and Technology; Minister of State (IC) Ministry of Earth Science; MoS of Prime Minister’s Office and Ministry of Personnel, Public Grievances & Pensions, Dr Jitendra Singh today launched Single National Portal for Biotech researchers and Start-ups.

The Portal “BioRRAP” will cater to all those seeking regulatory approval for biological research & development activity in the country and thus offer a huge relief for “Ease of Science as well as Ease of Business.

Speaking after the launch of the Biological Research Regulatory Approval Portal (BioRRAP), Dr Jitendra Singh said, India is poised to become a Global Bio-manufacturing Hub and will figure among the top 5 countries of the world by 2025.

The Minister says, India is poised for becoming a Global Bio-manufacturing Hub and will figure among the top 5 countries of the world by 2025
Dr Jitendra Singh said, the Portal will also allow stakeholders to see the approvals accorded against a particular application through a unique BioRRAP ID. He described this unique portal of DBT as a step towards Ease of Doing Science and Scientific research and Ease of Start-ups in India. The Minister said Biotechnology has fast emerged as an academic and livelihood avenue for youngsters in India. He also pointed out that there are over 2,700 biotech start-ups and more than 2,500 biotech companies working at present in the country.

Describing the launch of the Portal as the whole Govt approach in tune with Prime Minister Modi’s vision, Dr Jitendra Singh said, this portal will strengthen interdepartmental synergies and bring accountability, transparency and efficacy in the functioning of agencies regulating various aspects of biological research and issuing permits. Congratulating the Department of Biotechnology for launching the BioRRAP porta, the Minister suggested that the Department should endeavour to evolve further mechanisms to make the procedures simpler and more effective.

Dr Jitendra Singh pointed out that other than biotechnology, biological work related to biodiversity, the latest methods of conservation and protection of flora and fauna, forest and wildlife, bio-survey and bio-utilization of biological resources are also gaining momentum in India due to the effect of climate change on them. He added that research in the various biological fields is continuously expanding its vista in India supported by grants from various public and private sectors. Many of these research falls under the purview of one or more regulatory agencies which first approve the research proposal after which the researcher undertakes that specific research.

Dr Jitendra Singh says, “Biological Research Regulatory Approval Portal (BioRRAP) will help in ease of doing science, scientific research and ease of Start-ups in India

The Minister further added that at present there is no mechanism to track the requisite regulatory approval for a research proposal on a single portal and therefore, to provide more credibility and recognition to such biological research, the Government of India has developed a web system under which each research, requiring regulatory oversight, will be identified by a unique ID called “BioRRAP ID”. He said, the portal will serve as a gateway and will help researchers to see a stage of approval of their applications for regulatory clearances and to see preliminary information on all the research work being undertaken by the particular researcher and/or organization.

Dr Jitendra Singh directed the DBT officials for wider publicity of this unique National Portal and asked them to make short duration films capturing all the nuances of the registration and regulatory approval through the portal.

Over 2,700 biotech start-ups and more than 2,500 biotech companies working at present in the country
Coming back to India emerging as a Global Bio-manufacturing Hub, Dr Jitendra Singh informed that India is among the top 12 destinations for biotechnology globally and the 3rd largest biotechnology destination in the Asia Pacific region. The Minister said that by 2025, the contribution of the Indian biotechnology industry to the global biotechnology market is expected to grow to 19% from a mere 3% in 2017. He also added that the Bio Economy’s contribution to the national GDP has also grown steadily in the past years to 2.7% in 2020 from 1.7% in 2017 and will touch new heights after 25 years of the Bio-economy journey in the Centenary year of 2047.

Referring to the COVID pandemic, Dr Jitendra Singh lauded the strength of Indian Scientific organizations and enterprises and said that our institutions have come out with various vaccines, diagnostics and other tools which helped us to fight with Covid 19 situations. Further, our regulators are it the Department of Biotechnology, the Indian Council of Medical Research or the Central Drugs Standard Control Organization worked tirelessly to streamline the regulatory processes and reduce the timelines for approvals, the Minister added.

The contribution of the Indian biotechnology industry to the global biotechnology market to grow to 19% from a mere 3% in 2017 by 2025: Dr Jitendra Singh
The Minister underlined that during a pandemic, it was observed that there is a need to link the applications submitted to various regulatory agencies for approval so as the status of the application may be seen in one place. Further, it was also felt that as a country we should have a repository of the research works being undertaken by our researchers working in the public and private sectors. This will not only help us in understanding our scientific strength and expertise but also in the formulation of enabling policies to garner the fruits of scientific research.

In his address, Secretary, Department of Biotechnology, Dr Rajesh S Gokhale said that BioRRAP has been developed that generates BioRRAP ID for all the research applications submitted on this portal and using this BioRRAP Id, further submission process to respective regulatory agencies has to be initiated based on the research application. He said this portal is dedicated only to research-related activities and not to product development.

News Hunt Daily Evening Paper

21 May 2022
Page 1
#news #breakingnews #epaper #Newshunt #latestnews #LatestUpdates

News Hunt Daily Evening Paper

21 May 2022
Page 4
#news #breakingnews #epaper #Newshunt #latestnews #LatestUpdates

Marvel’s ‘Daredevil’ is to return for the Disney+ series.

0

Marvel’s Daredevil series is allegedly set to be resuscitated on Disney+.
As per Variety, Matt Corman and Chris Ord have been recruited to compose and chief produce another Daredevil series inside the Marvel Cinematic Universe.
The pair are most popular for co-making the USA Network series Covert Affairs.
While Marvel hasn’t authoritatively affirmed the task, two stars from the Netflix Daredevil series – Charlie Cox and Vincent D’Onofrio – have both showed up in ongoing Marvel trips.
Cox repeated his job of Matt Murdock otherwise known as Daredevil in Spider-Man: No Way Home, while D’Onofrio returned as Wilson Fisk otherwise known as Kingpin in the Disney+ series Hawkeye.
Netflix’s Daredevil series was dropped in 2018 after three seasons, close by Marvel’s different shows on the stage – Luke Cage, Jessica Jones, Iron Fist, and The Punisher.
Each of the five shows has since been delivered on Disney+, alongside the hybrid series The Defenders.
Marvel has a colossal record of Disney+ shows in progress. Ms. Marvel featuring Iman Vellani is set to be their next project on June 8.
This will be trailed by She-Hulk: Attorney At Law in August, with Secret Invasion, Ironheart, and Echo all set for discharge one year from now.
There have been six MCU shows up until this point, including WandaVision, The Falcon And The Winter Soldier, and Loki.

दो बार के कॉमनवेल्थ खेलों के पदक विजेता प्रभपाल सिंह का फोर्टिस मोहाली में एडवांस्ड हाइब्रिड एसीएल सर्जरी के साथ सफलतापूर्वक इलाज किया गया

जालंधर मई (न्यूज़ हंट)- फोर्टिस हॉस्पिटल, मोहाली में ऑर्थोपेडिक्स टीम ने हाल ही में 2016 कॉमनवेल्थ खेलों के स्वर्ण पदक विजेता (कुश्ती) प्रभपाल सिंह की एसीएल टीयर और मेनिस्कस की चोट के लिए सफलतापूर्वक सर्जरी प्रोसीजर को पूरा किया। एसीएल घुटने में एक लिगामेंट है जो स्थिरता को नियंत्रित करता है और खेलकूद के लिए महत्वपूर्ण है। एसीएल इसमें टीयर (आंतरिक तौर पर फटना) से खेल करियर का नुकसान होता है, और इससे बड़े झटके लग सकते हैं। मेनिस्कस घुटने में एक कुशन है और आमतौर पर खेलने के दौरान क्षतिग्रस्त हो जाता है।

रोगी प्रभपाल को असहनीय दर्द हो रहा था और इससे मैदान पर उसका प्रदर्शन प्रभावित हो रहा था। 2016 के कॉमनवेल्थ खेलों में कुश्ती में स्वर्ण पदक और 2017 में उसी खेल स्पर्धा में रजत पदक जीतने वाले प्रभपाल अपनो स्पोर्ट्स इंजरी के कारण खेल को छोडऩे पर विचार कर रहे थे।

आखिरकार उन्होंने इस साल मार्च में फोर्टिस हॉस्पिटल मोहाली के ऑर्थोपेडिक्स और स्पोर्ट्स मेडिसिन के सलाहकार डॉ. मानित अरोड़ा से मुलाकात की और उसके बाद 22 मार्च को हाइब्रिड एसीएल सर्जरी करवाई। एसीएल सर्जरी के लिए हाइब्रिड एसीएल सर्जरी एक नई तकनीक है जो देशी शरीर रचना को बहाल करने में मदद करती है, पुनर्वास में तेजी लाती है और संबंधित खेल में रोगी की वापसी होती है।

फोर्टिस मोहाली में अच्छे रीहैबलीटेशन प्रोग्राम के बाद, रोगी प्रभपाल को सर्जरी के अगले दिन छुट्टी दे दी गई और वह बिना किसी सहारे के चलने में सक्षम हो गए। डॉ. अरोड़ा ने खुलासा किया कि रोगी प्रभपाल 6 महीने के भीतर कुश्ती में वापसी करने में सक्षम होंगे।

इस पूरे केस प्रीसजर के बारे में विस्तार से चर्चा करते हुए, डॉ. अरोड़ा ने कहा कि ‘‘रोगी के एसीएल टीयर और मेनिस्कस की चोट थी जो मैदान पर उसके प्रदर्शन को बाधित कर रही थी। मैंने हाइब्रिड एसीएल सर्जरी की सबसे एडवांस्ड तकनीक के माध्यम से उनके घुटने का ऑपरेशन किया। रोगी प्रभपाल के 6 महीने के भीतर खेल के मैदान में वापसी करने की संभावना है।’’

ਬੱਚਿਆਂ ਦੀ ਭਲਾਈ ਲਈ ਕੰਮ ਕਰ ਰਹੀਆਂ ਸੰਸਥਾਵਾਂ 30 ਮਈ ਤੱਕ ਕਰਵਾਉਣ ਰਜਿਸਟ੍ਰੇਸ਼ਨ-ਡਿਪਟੀ ਕਮਿਸਨਰ

ਪਠਾਨਕੋਟ 20 ਮਈ (ਨਿਊਜ਼ ਹੰਟ)- ਜਿਲ੍ਹੇ ਵਿੱਚ ਚੱਲ ਰਹੀਆਂ ਗੈਰ ਸਰਕਾਰੀ ਸੰਸਥਾਵਾਂ ਜ਼ੋ ਕਿ 0 ਤੋਂ 18 ਸਾਲ ਤੱਕ ਦੇ ਬੱਚਿਆਂ ਦੀ ਭਲਾਈ ਦੇ ਖੇਤਰ ਵਿੱਚ ਕੰਮ ਕਰ ਰਹੀਆਂ ਹਨ, ਨੂੰ ਸੂਚਿਤ ਕੀਤਾ ਜਾਂਦਾ ਹੈ ਕਿ ਜ਼ੋ ਸੰਸਥਾਵਾਂ ਮੁਕੰਮਲ ਤੋਰ ਤੇ ਜਾਂ ਅੰਸ਼ਿਕ ਰੂਪ ਵਿੱਚ ਸੁਰੱਖਿਆ ਅਤੇ ਸੰਭਾਲ ਲਈ ਲੋੜਬੰਦ ਬੱਚਿਆਂ ਨੂੰ ਫਰੀ ਰਿਹਾਇਸ਼, ਖਾਣਾ, ਪੜ੍ਹਾਈ, ਮੈਡੀਕਲ੍ਹ ਸੁਵਿਧਾ ਆਦਿ ਮੁੱਹਇਆਂ ਕਰਵਾ ਰਹੀਆਂ ਹਨ, ਦਾ ਜੁਵੇਨਾਇਲ ਜ਼ਸਟਿਸ (ਕੇਅਰ ਐਂਡ ਪ੍ਰੋਟੈਕਸ਼ਨ ਆਫ ਚਿਲਡਰਨ) ਐਕਟ, 2015 ਦੀ ਧਾਰਾ 41(1) ਅਧੀਨ ਰਜਿਸਟਰਡ ਹੋਣਾ ਲਾਜ਼ਮੀ ਹੈ। ਇਸ ਲਈ ਜਿਲ੍ਹੇ ਵਿੱਚ ਜ਼ੋ ਗੈਰ ਸਰਕਾਰੀ ਸੰਸਥਾਵਾਂ ਅਜੇ ਤੱਕ ਇਸ ਐਕਟ ਅਧੀਨ ਰਜਿਸਟਰਡ ਨਹੀਂ ਹਨ, ਉਹ 30.05.2022 ਤੋਂ ਪਹਿਲਾਂ-ਪਹਿਲਾਂ ਦਫਤਰ ਜਿਲ੍ਹਾ ਪੋ੍ਰਗਰਾਮ ਅਫਸਰ/ਜਿਲ੍ਹਾ ਬਾਲ ਸੁਰੱਖਿਆ ਅਫਸਰ, ਪਠਾਨਕੋਟ ਵਿਖੇ ਨੋਟੀਫਾਈਡ ਜੇ.ਜੇ ਮਾਡਲ ਰੂਲਜ਼ ਦੇ ਫਾਰਮ ਨੰ: 27 ਅਨੁਸਾਰ ਆਪਣੇ ਦਸਤਾਵੇਜ਼ ਜਮ੍ਹਾਂ ਕਰਵਾਉਣ। ਇਹ ਪ੍ਰਗਟਾਵਾ ਸ. ਹਰਬੀਰ ਸਿੰਘ ਡਿਪਟੀ ਕਮਿਸਨਰ ਪਠਾਨਕੋਟ ਵੱਲੋਂ ਕੀਤਾ ਗਿਆ।

ਉਨ੍ਹਾਂ ਕਿਹਾ ਕਿ ਜੇਕਰ ਮਿਤੀ 30.05.2022 ਤੋਂ ਬਾਅਦ ਇਹ ਪਾਇਆ ਜਾਂਦਾ ਹੈ ਕਿ ਜਿਲ੍ਹੇ ਵਿੱਚ ਗੈਰ ਸਰਕਾਰੀ ਸੰਸਥਾ ਜ਼ੋ ਕਿ ਬੱਚਿਆ ਦੀ ਭਲਾਈ ਦੇ ਖੇਤਰ ਵਿੱਚ ਕੰਮ ਕਰ ਰਹੀ ਹੈ, ਪ੍ਰੰਤੂ ਜੁਵੇਨਾਇਲ ਜ਼ਸਟਿਸ (ਕੇਅਰ ਐਡ ਪ੍ਰੋਟੈਕਸ਼ਨ ਆਫ ਚਿਲਡਰਨ) ਐਕਟ, 2015 ਦੀ ਧਾਰਾ 41(1) ਅਧੀਨ ਰਜਿਸਟਰਡ ਨਹੀਂ ਹੈ, ਤਾਂ ਉਸ ਸੰਸਥਾ ਦੇ ਵਿਰੁੱਧ ਜੁਵੇਨਾਇਲ ਜ਼ਸਟਿਸ (ਕੇਅਰ ਐਂਡ ਪੋ੍ਰਟੈਕਸ਼ਨ ਆਫ ਚਿਲਡਰਨ) ਐਕਟ, 2015 ਦੀ ਧਾਰਾ 42 ਅਨੁਸਾਰ ਕਾਰਵਾਈ ਕੀਤੀ ਜਾਵੇਗੀ। ਸਸੰਥਾਂ ਨੂੰ ਰਜਿਸਟਰਡ ਕਰਵਾਉਣ ਦੀ ਜਾਣਕਾਰੀ ਲੈਣ ਲਈ ਦਫਤਰ ਜਿਲ੍ਹਾ ਬਾਲ ਸੁਰੱਖਿਆ ਅਫਸਰ, ਪਠਾਨਕੋਟ ਬਲਾਕ ਸੀ, ਕਮਰਾ ਨੰਬਰ 138, ਜਿਲ੍ਹਾ ਪ੍ਰਬੰਧਕੀ ਕੰਪਲੈਕਸ, ਮਲਿਕਪੁਰ (ਫੋਨ ਨੰ:8559063371,8968033481) ਵਿਖੇ ਆ ਕੇ ਸੰਪਰਕ ਕੀਤਾ ਜਾਵੇ।